Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Usana Health SciencesSTU:USJ +3.78%67 Buyback Yield % is 3.68 as of Jul. 21, 2026, which is 17% below its 10-year median of 4.45. GuruFocus rates STU:USJ with a GF Score™ of 67/100 and a GF Value™ of €35.51 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 552 Consumer Packaged Goods companies, Usana Health Sciences ranks better than 92.03% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
Usana Health Sciences Buyback Yield % Related Terms
Usana Health Sciences Buyback Yield % Historical Data
* Premium members only.
The historical data trend for Usana Health Sciences's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:USJ vs NATR, ENHA, BYND: Buyback Yield % Comparison
For the Packaged Foods subindustry, Usana Health Sciences's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Usana Health Sciences Buyback Yield % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Usana Health Sciences's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Usana Health Sciences's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Usana Health Sciences (STU:USJ) has a Buyback Yield % of 3.68 as of Jul. 21, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Usana Health Sciences and its competitors. This is 17% below median its historical median of 4.45. Over the past decade, Usana Health Sciences' Buyback Yield % has ranged from 0.11 to 15.53. According to the industry distribution chart, Usana Health Sciences ranks #44 out of 552 companies in the Consumer Packaged Goods industry, placing it in the top 8%.
Is Usana Health Sciences' Buyback Yield % too high?
Usana Health Sciences' current Buyback Yield % of 3.68 is 17% below median its 10-year median of 4.45. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 15.53. Based on the distribution chart, Usana Health Sciences ranks #44 out of 552 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Usana Health Sciences has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Usana Health Sciences' Buyback Yield % compare to NATR and ENHA?
According to the Consumer Packaged Goods industry distribution chart, Usana Health Sciences ranks #44 out of 552 companies for Buyback Yield %. This places Usana Health Sciences in the top 8% of its industry — outperforming the majority of peers. Historically, Usana Health Sciences' own Buyback Yield % has ranged from 0.11 to 15.53 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Consumer Packaged Goods company?
A good Buyback Yield % depends on the Consumer Packaged Goods industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Usana Health Sciences and its competitors. Usana Health Sciences's current Buyback Yield % is 3.68, which is 17% below median its own 10-year median of 4.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Usana Health Sciences stock overvalued right now?
Based on GuruFocus' analysis, Usana Health Sciences (STU:USJ) is currently considered Possible Value Trap. The stock's GF Value™ is €35.51, compared to a current price of €19.20 — trading 45.9% below its estimated fair value. The current Buyback Yield % is 3.68, which is 17% below median its 10-year median of 4.45. Usana Health Sciences' overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Usana Health Sciences (STU:USJ), the current Buyback Yield % is 3.68 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Usana Health Sciences (STU:USJ) Overvalued in 2026?
Based on GuruFocus' analysis, Usana Health Sciences stock appears to be undervalued.
The current stock price of €19.20 is trading 45.9% below its estimated GF Value™ of €35.51.
GuruFocus considers Usana Health Sciences to be Possible Value Trap.
Key valuation signals for STU:USJ:
Buyback Yield %: 3.68 (17% below median its 10-year median of 4.45)
GF Value™: €35.51 vs. price of €19.20 (45.9% below fair value)
No single metric tells the full story. See the STU:USJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
67GF Score
Get the complete analysis for STU:USJ
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:USJ has been successfully added to your 
